PF-01247324
- CAS No.
- 875051-72-2
- Chemical Name:
- PF-01247324
- Synonyms
- 133786;CS-2577;PF-1247324;PF-01247324;PF01247324;PF 01247324;PF-01247324, 10 mM in DMSO;6-amino-N-methyl-5-(2,3,5-trichlorophenyl)picolinamide;6-AMINO-N-METHYL-5-(2,3,5-TRICHLOROPHENYL)PYRIDINE-2-CARBOXAMIDE;2-PyridinecarboxaMide, 6-aMino-N-Methyl-5-(2,3,5-trichlorophenyl)-;6-AMINO-5-(2,3,5-TRICHLORO-PHENYL)-PYRIDINE-2-CARBOXYLIC ACID METHYLAMIDE
- CBNumber:
- CB42682530
- Molecular Formula:
- C13H10Cl3N3O
- Molecular Weight:
- 330.6
- MDL Number:
- MFCD28156579
- MOL File:
- 875051-72-2.mol
- MSDS File:
- SDS
Boiling point | 477.7±45.0 °C(Predicted) |
---|---|
Density | 1.460±0.06 g/cm3(Predicted) |
storage temp. | room temp |
solubility | DMF: 30 mg/ml; DMSO: 30 mg/ml; Ethanol: 30 mg/ml; Ethanol:PBS (pH 7.2) (1:4): 0.2 mg/ml |
pka | 6.56±0.46(Predicted) |
form | powder |
color | white to beige |
UNSPSC Code | 41121801 |
NACRES | NA.77 |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS06 |
---|---|
Signal word | Danger |
Hazard statements | H301-H315-H319-H335 |
Precautionary statements | P301+P310+P330-P302+P352-P305+P351+P338 |
RIDADR | UN 2811 6.1 / PGIII |
PF-01247324 price More Price(14)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich | PZ0274 | PF-01247324 ≥98% (HPLC) | 875051-72-2 | 5MG | $115 | 2023-06-20 | Buy |
Sigma-Aldrich | PZ0274 | PF-01247324 ≥98% (HPLC) | 875051-72-2 | 25MG | $451 | 2023-06-20 | Buy |
Cayman Chemical | 22111 | PF-01247324 ≥98% | 875051-72-2 | 1mg | $33 | 2024-03-01 | Buy |
Cayman Chemical | 22111 | PF-01247324 ≥98% | 875051-72-2 | 5mg | $96 | 2024-03-01 | Buy |
Cayman Chemical | 22111 | PF-01247324 ≥98% | 875051-72-2 | 10mg | $176 | 2024-03-01 | Buy |
PF-01247324 Chemical Properties,Uses,Production
Description
PF-01247324 is a blocker of the tetrodotoxin-resistant (TTX-R) sodium channel Nav1.8 (IC50 = 0.19 μM for human Nav1.8). It is selective for Nav1.8 over Nav1.1, Nav1.2, Nav1.5, and Nav1.7 channels (IC50s = 13, 12.8, 9, and 19 μM, respectively) as well as ether-a-go-go (ERG) potassium channels (IC50 = 30 μM). PF-01247324 blocks Nav1.8 channels in a VSP-FRET assay using HEK293 cells (IC50 = 2.6 μM). In vivo, PF-01247324 (100 mg/kg) reduces phase 2 flinching in a rat model of formalin-induced persistent pain. It increases latency to lift the inflamed paw and latency to paw withdrawal in rat models of carrageenan-induced thermal hyperalgesia and mechanical hyperalgesia induced by complete Freund''s adjuvant (CFA), respectively.
Uses
6-Amino-N-methyl-5-(2,3,5-trichlorophenyl)picolinamide is a Nav1.8 modulators that demonstrate efficacy in preclinical models of neuropathic and inflammatory pain, attenuates nociception and sensory neuron excitability.
Biochem/physiol Actions
In humans, PF-01247324 [6-amino-5-(2, 3, 5-trichloro-phenyl)-pyridine-2-carboxylic acid methylamide] prevents native tetrodotoxin-resistant (TTX-R) currents in dorsal root ganglion (DRG) neurons.
Enzyme inhibitor
This novel oral NaV1.8 blocker (FW = 330.59 g/mol) attenuates nociception and neuronal excitability by selectively targeting voltage-gated sodium transporter NaV1.8, with much weaker action against NaV1.1, NaV1.2, NaV1.4, NaV1.5, NaV1.6, and NaV1.7 transporters. PF-01247324 inhibited native tetrodotoxin-resistant (TTX-R) currents in human dorsal root ganglion (DRG) neurons (IC50 = 331 nM) and in recombinantly expressed hNav 1.8 (IC50 = 196 nM), with 50-fold selectivity over recombinantly expressed TTX-R hNav 1.5 channels (IC50 ~ 10 μM) and 65-100 greater selectivity over TTX-sensitive (TTX-S) channels (IC50 ~ 10-18 μM). Native TTX-R currents in small diameter rodent DRG neurons were inhibited with an IC50 of 448 nM, and the block of both human recombinant Nav1.8 and TTX-R from rat DRG neurons was both frequency and statedependent. Unlike previously published NaV1.8 blockers, PF-01247324 demonstrates frequency-dependence, and off-target frequency-dependence at other sodium channel subtypes may reduce its selectivity window. The majority of small molecule sodium channel blockers interact at the local anesthetic binding site, which due to a high level of sequence homology across voltage-gated sodium channel subtypes seems an unlikely site for interaction of selective agents such as PF-01247324. The majority of small molecule sodium channel blockers interact at the local anesthetic binding site, which due to a high level of sequence homology across voltage-gated sodium channel subtypes seems an unlikely site for interaction of selective agents such as PF-01247324
PF-01247324 Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32965 | 60 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32161 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6391 | 58 |
TargetMol Chemicals Inc. | support@targetmol.com | United States | 38631 | 58 | |
ShenZhen Trendseen Biological Technology Co.,Ltd. | 13417589054 | trendseenbio@gmail.com | China | 11681 | 58 |
Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131957 | 58 |
ChemShuttle, Inc. | 0510-83588313-811 18800520310; | sales@chemshuttle.com | China | 2999 | 62 |
Modachem Shanghai Co., Ltd | +86 (0)21 51320687 51371369 1744605818 | China | 1578 | 58 | |
Sigma-Aldrich | 021-61415566 800-8193336 | orderCN@merckgroup.com | China | 51456 | 80 |
Shanghai Lollane Biological Technology Co.,Ltd. | 021-52996696,15000506266 15000506266 | China | 4569 | 55 |
View Lastest Price from PF-01247324 manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
![]() |
2024-11-19 | PF-01247324
875051-72-2
|
US $67.00-243.00 / mg | 99.47% | 10g | TargetMol Chemicals Inc. |
-
- PF-01247324
875051-72-2
- US $67.00-243.00 / mg
- 99.47%
- TargetMol Chemicals Inc.